Table 2.
Mab name | Immunogen | Epitope type | Mab type | Titers | IFA | ‡SVN | |
---|---|---|---|---|---|---|---|
Supernatants | Ascitic fluid | ||||||
15G9 | R345-BSA | Linear | IgG1, Kappa | 6400 | 409600 | †+ | + |
12C10 | R405-BSA | Linear | IgG1, Kappa | 6400 | 819200 | + | + |
10D2 | R465-BSA | Linear | IgG1, Kappa | 800 | 409600 | + | + |
†Positive result.
‡Neutralization activity of the mAbs were assessed by a commercial SARS-CoV-2 surrogate virus neutralization test kit (Genscript, Nanjing, China).